Effectiveness of Ramadan diurnal intermittent fasting and concurrent training in the management of obesity: is the combination worth the weight?


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
03 2023
Historique:
received: 07 05 2022
revised: 27 11 2022
accepted: 07 12 2022
pubmed: 30 1 2023
medline: 25 2 2023
entrez: 29 1 2023
Statut: ppublish

Résumé

We investigated, in men with obesity, the efficacy of the combination of two strategies (Ramadan diurnal intermittent fasting 'RDIF' strategy vs RDIF plus concurrent training program 'RDIF-CT' strategy) known for their positive impact on body composition and then we explored the possible impact on metabolic and inflammatory biomarkers. Twenty obese men, age: 31.8 ± 7.05 years, BMI: 33.1 ± 4.2 kg m Our results suggest that a combination of RDIF and CT induces greater changes in body composition, lipid profile, inflammation and liver biomarkers compared to RDIF strategy alone. PACTR202203475387226.

Sections du résumé

BACKGROUND AND AIMS
We investigated, in men with obesity, the efficacy of the combination of two strategies (Ramadan diurnal intermittent fasting 'RDIF' strategy vs RDIF plus concurrent training program 'RDIF-CT' strategy) known for their positive impact on body composition and then we explored the possible impact on metabolic and inflammatory biomarkers.
METHODS AND RESULTS
Twenty obese men, age: 31.8 ± 7.05 years, BMI: 33.1 ± 4.2 kg m
CONCLUSIONS
Our results suggest that a combination of RDIF and CT induces greater changes in body composition, lipid profile, inflammation and liver biomarkers compared to RDIF strategy alone.
CLINICAL TRIAL REGISTER
PACTR202203475387226.

Identifiants

pubmed: 36710112
pii: S0939-4753(22)00491-4
doi: 10.1016/j.numecd.2022.12.004
pii:
doi:

Substances chimiques

Blood Glucose 0
Lipids 0
Biomarkers 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-666

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Rami Maaloul (R)

High Institute of Sport and Physical Education of Sfax, University of Sfax, Tunisia; Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Tunisia.

Houssem Marzougui (H)

High Institute of Sport and Physical Education of Sfax, University of Sfax, Tunisia; Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Tunisia.

Imen Ben Dhia (I)

High Institute of Sport and Physical Education of Sfax, University of Sfax, Tunisia; Research Laboratory of Evaluation and Management of Musculoskeletal System Pathologies, LR20ES09, University of Sfax, Tunisia.

Sameh Ghroubi (S)

Research Laboratory of Evaluation and Management of Musculoskeletal System Pathologies, LR20ES09, University of Sfax, Tunisia.

Sémah Tagougui (S)

Montreal Clinical Research Institute, Montreal, Canada; Université de Lille, Université d'Artois, Université du Littoral Côte d'Opale, ULR 7369-URePSSS-Unité de Recherche Pluridisciplinaire Sport Santé Société, Lille, France.

Choumous Kallel (C)

Hematology laboratory, CHU Habib Bourguiba, Sfax, Tunisia.

Tarak Driss (T)

Interdisciplinary Laboratory in Neurosciences, Physiology and Psychology: Physical Activity, Health and Learning (LINP2), UFR STAPS, UPL, Paris Nanterre, Nanterre, France.

Mohamed Habib Elleuch (MH)

Research Laboratory of Evaluation and Management of Musculoskeletal System Pathologies, LR20ES09, University of Sfax, Tunisia.

Fatma Ayadi (F)

Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Tunisia.

Mouna Turki (M)

Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Tunisia.

Omar Hammouda (O)

Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Tunisia; Interdisciplinary Laboratory in Neurosciences, Physiology and Psychology: Physical Activity, Health and Learning (LINP2), UFR STAPS, UPL, Paris Nanterre, Nanterre, France. Electronic address: hammouda.o@parisnanterre.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH